Fresenius Kabi USA has initiated a voluntary nationwide recall of three lots of famotidine injection, USP 20 mg/2 mL (10 mg/mL, 2 mL vial), according to a company announcement posted on the FDA ...
Famotidine Injection is indicated in some hospitalized patients with pathological hypersecretory conditions or intractable ulcers, or as an alternative to the oral dosage forms for short term use in ...
In the table of the release dated Nov 6, 2025, First Ship Date for Batch Number 6133388 should be 04/15/2025.
Three lots (numbers 6133156, 6133194, 6133388) of Famotidine Injection are being recalled in the U.S. by Fresenius Kabi. Three lots (numbers 6133156, 6133194, 6133388) of Famotidine Injection are ...
Fresenius Kabi, part of the global healthcare company Fresenius, and a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical ...
In the table of the release dated Nov 6, 2025, First Ship Date for Batch Number 6133388 should be 04/15/2025. Javascript is required for you to be able to read ...
Objective We assessed whether famotidine improved inflammation and symptomatic recovery in outpatients with mild to moderate COVID-19. Design Randomised, double-blind, placebo-controlled, fully remote ...
Columnist G Shellye Horowitz applied the advocacy she learned on her hemophilia journey to get a new rare diagnosis. She ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results